+987.9%
MRNA vs AMC
+38.0%
+949.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AMC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +7.3% | +5.8% | +11.2% |
| 7D | +20.6% | +17.7% | +2.9% | +16.0% |
| 30D | +27.1% | +26.2% | +1.0% | +20.4% |
| 3M | +353.4% | +31.3% | +322.0% | +318.8% |
| 6M | +446.3% | +142.8% | +303.5% | +373.2% |
| YTD | +776.2% | +125.6% | +650.5% | +662.1% |
| 1Y | +987.9% | +40.2% | +947.7% | +1,059.4% |
| All | +987.9% | +38.0% | +949.9% | +1,059.4% |
Cumulative growth
Daily Returns
Daily percentage return beside AMC.
Daily Out/Under-Performance
Portfolio return minus AMC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AMC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling